These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 2973884

  • 1. [Medical treatment of obliterating arteriopathies of the lower limbs with vasoactive drugs].
    Raspanti D, Cameli AM, Trapani M, Dorigo D, Mazzotta A, Negro P.
    Clin Ter; 1987 Jun 30; 121(6):479-83. PubMed ID: 2973884
    [No Abstract] [Full Text] [Related]

  • 2. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
    Spinella G, Majorana M.
    Clin Ter; 1983 Mar 15; 104(5):375-81. PubMed ID: 6303677
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of chronic arterial vascular disorders with Complamin and Complamin retard].
    Musil HE.
    Med Welt; 1973 Jan 19; 24(3):103-13. PubMed ID: 4617835
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical trial of xanthinol nicotinate in delayed form in the treatment of arteritis of the lower limbs].
    Niquet G, Dupont T.
    Lille Med; 1976 Jan 19; 21(1 suppl 1):13-5. PubMed ID: 1256225
    [No Abstract] [Full Text] [Related]

  • 5. The use of Xavin infusions in obliterating peripheral arterial disorders.
    Keller L, Landi A, Bársony J.
    Ther Hung; 1975 Jan 19; 23(2):54-9. PubMed ID: 1188703
    [No Abstract] [Full Text] [Related]

  • 6. [Xanthinic derivatives in the treatment of intermittent claudication syndrome in diabetic patients].
    Gómez Reyes D, Rojas Hidalgo E.
    Rev Clin Esp; 1986 Jul 19; 179(3):162. PubMed ID: 3764000
    [No Abstract] [Full Text] [Related]

  • 7. [Transcutaneous oxygen pressure during intra-arterial infusions].
    Creutzig A, Dau D, Alexander K.
    Vasa; 1984 Jul 19; 13(3):207-12. PubMed ID: 6485524
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of a 3-month-interval running exercise in combination with vasodilative therapy on microcirculation of the lower leg in peripheral arterial circulation disorders (stage I and II)].
    Siewert H, Winterfeld HJ, Strangfeld D, Schmidt HH, Correns HJ.
    Z Alternsforsch; 1983 Jul 19; 38(5):377-81. PubMed ID: 6659566
    [Abstract] [Full Text] [Related]

  • 9. [Therapeutic results with xanthine derivatives in the intermittent claudication syndrome in diabetic patients].
    Gómez Reyes D, Rojas Hidalgo E.
    Rev Clin Esp; 1988 Jan 19; 182(1):3-6. PubMed ID: 3375512
    [No Abstract] [Full Text] [Related]

  • 10. [Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
    Benignetti G, Fabbri F, Benvenuti C.
    Clin Ter; 1983 Feb 28; 104(4):297-304. PubMed ID: 6861465
    [No Abstract] [Full Text] [Related]

  • 11. Levodopa in the treatment of arterial insufficiency of the lower limbs. Clinical and rheographic trial.
    Vaccaro E, Solitro A, Barba C.
    Arzneimittelforschung; 1973 Dec 28; 23(12):1793-8. PubMed ID: 4205907
    [No Abstract] [Full Text] [Related]

  • 12. [Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study].
    Andreozzi GM, Lepore R.
    Clin Ter; 1990 Nov 30; 135(4):273-81. PubMed ID: 2150026
    [Abstract] [Full Text] [Related]

  • 13. [Effects of proxazole on patients with obliterating arteriopathy of the lower limbs].
    Saponaro A, Russo R, Tomei F, Giordano M, Dragagna G, Barbato G.
    Clin Ter; 1979 Dec 31; 91(6):585-92. PubMed ID: 544162
    [No Abstract] [Full Text] [Related]

  • 14. Acute effect of xanthinol nicotinate on the muscle clearance of 133Xenon.
    Szilvási I, Molnár G.
    Ther Hung; 1973 Dec 31; 21(3-4):114-6. PubMed ID: 4806418
    [No Abstract] [Full Text] [Related]

  • 15. [Use of xavin in vascular diseases of the lower extremities].
    Volgin EG.
    Klin Med (Mosk); 1980 Oct 31; 58(10):46-50. PubMed ID: 7442096
    [No Abstract] [Full Text] [Related]

  • 16. Xanthinol nicotinate in peripheral vascular disease.
    Davis E, Rozov H.
    Practitioner; 1975 Dec 31; 215(1290):793-8. PubMed ID: 772653
    [Abstract] [Full Text] [Related]

  • 17. [Drug therapy of hyperlipemia. Experiences with xanthinol nicotinate retard-capsules in a general practice].
    Klimm HD.
    Med Monatsschr; 1976 Apr 31; 30(4):178-80. PubMed ID: 958145
    [No Abstract] [Full Text] [Related]

  • 18. [Gangliectomy in the treatment of obliterating arterial diseases of the lower extremities].
    Sitenko VM.
    Vestn Khir Im I I Grek; 1979 Jun 31; 122(6):3-9. PubMed ID: 452296
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of the efficacy of medical treatment, especially anticoagulant treatment, in arteriopathies of the lower limbs. Apropos of 41 cases].
    Chérif T, Kallel N, Guediche M.
    Tunis Med; 1986 May 31; 64(5):475-80. PubMed ID: 3824555
    [No Abstract] [Full Text] [Related]

  • 20. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May 23; 144(21):54. PubMed ID: 12134429
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.